Skip to main content

Table 1 Patients’ characteristics at baseline

From: The efficacy and dosimetry analysis of CT-guided 125I seed implantation assisted with 3D-printing non-co-planar template in locally recurrent rectal cancer

Characteristic

Value

Number

66

Sex, n (%)

 Male

38 (57.6%)

 Female

28 (42.4%)

Age (in years), median (range)

56 (32–79)

  ≤ 40

3 (4.5%)

 40–50

17 (25.8%)

 50–60

26 (39.4%)

 >60

20 (30.3%)

Karnofsky performance score (%), median (range)

81 (60–90)

Recurrent pattern a, n (%)

 Sacral invasive type

31 (47.0%)

 Lateral invasive type

19 (28.8%)

 Localized type

16 (24.2%)

Histopathology

 Adenocarcinoma

63

 Adenosquamous carcinoma

3

Previous surgery

 None

3

 Once

49

 Twice

14

Total dose of previous EBRT (Gy)

  < 50

7

 50–100

47

  > 100

12

Courses of previous EBRT

 0

4

 1

46

 2

13

 3

3

Gross tumor volume (ml), average ± standard deviation

46.0 ± 48.9

Time from tumor recurrence to RIS implantation (in months), median (range)

16 (0.5–62)

  1. a: Sacral invasive type: invasion of lower sacrum (S3, S4, S5), coccyx or periosteum; Lateral invasive type: invasion of upper sacrum (S1, S2), sciatic nerve, greater sciatic foramen or lateral pelvic wall; Localized type: invasion of surrounding pelvic organs or tissue s[12]. EBRT: external beam radiotherapy; RIS: radioactive 125I seed